Trial Profile
SWITCH 600/60: The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Thrombosis
- Focus Pharmacodynamics
- Acronyms SWITCH 600/60
- 27 Dec 2019 Status changed from active, no longer recruiting to completed.
- 31 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Mar 2013 Planned End Date changed from 1 Dec 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.